Over 25+ years of experience in professional services, Dr. Wu is a visionary, seasoned, and dynamic professional, offering in-depth scientific, regulatory, and clinical knowledge of developing medical devices including IVD and innovative medical devices, focused on driving corporate growth and innovation by translating goals/objectives into actionable strategies/operating plans that support the business.

Dr. Wu has led cross-functional teams responsible for product development, scale-up manufacturing, supply-chain management, and GMP compliance. Worked collaboratively with client’s executive management, board of directors, consultants, and outside thought leaders to shape clinical and regulatory strategy/direction fir HMC’s clients.

Before the foundation of HMC, Dr. Wu worked in various consulting roles at PwC, Lucent Technologies, has served in many pharmaceutical companies such as Pfizer, healthcare institution such as Memorial Sloan  Kettering Cancer Center, Hospital for Special Surgery, Atlantic Health System, etc.

Dr. Wu obtained his Ph.D. in Physics from New York University, and an M.S. in Computer Science and M.S. in Electrical Engineering also from New York University.

Over 25+ years of nursing and leadership experience in both clinical research and critical care, she has served in clinical operation director role in many health systems including Valley Health System, Cardiopulmonary Research Science and Technology Institute, UT Southwestern Medical Center. Her clinical expertise across different phases of trial, managed 125+ drug and device trials (Phases II-IV) in numerous therapeutic areas. She has established local Institutional Review Board/provided oversight and training for many of her client’s before joining HMC.

As the Director of Clinical operation, Jennifer has primarily responsible for overseeing the operational efficiency and quality of clinic services at all clinic sites, including direct supervision of Site Managers, and lead efforts to improve quality outcomes and clinic operations in a way that contributes to an enhanced experience for staff and patients, oversee the functioning of key systems vital to clinic operations.

Jennifer obtained her M.S. in Nursing from University of Texas at Arlington, and Bachelors of Science in Nursing     from Texas Christian University.

With over 25+ years of strong experience in the pharmaceutical and medical device clinical research industry, Dr. Zhou has thorough and demonstrated knowledge of methods of analysis used in Clinical Laboratories, and In-depth knowledgeable of fiscal and general healthcare issues, trends, quality management. Dr. Zhou has extensive experience in laboratory equipment and automation and laboratory practice & standards, good understanding of scientific methodology and clinical study design.

Before joining HMC, Dr. Zhou has played Laboratory Director roles in many prestigious laboratories including: Paradigm Laboratories, Hangzhou Medical Biotechnology Clinical Laboratory, BAS Premier Laboratory, ViaGen, etc, the molecular diagnostic tests offered in these labs included the tests for infectious diseases, inherited conditions, precision medicine for chronic disease management, cancer companion diagnostics and prognostics, and pharmacogenetics.

Dr. Zhou obtained her Ph.D. in Biochemistry from Arizona State University.

Master of Business Administration MBA 

Clinical Research and Healthcare Administrator, Advance innovative discoveries for the treatment of human disease.

Life Science professional and strategist with over 15 years of experience building disruptive partnerships across academia, CROs, diagnostics, biotechnology, pharmaceutical and medical device organizations.

Andrew's professional goal is to successfully impact healthcare organizations to advance innovative therapeutic discoveries for the treatment of human disease.

Highly recognized for accomplishments with Clinical Research Operations, Project Management, Business Development and Sponsored Research Funding within Healthcare Clinical Research. These results maximize efficiencies and accelerate cost-effective drug, medical device and therapeutic development.

Sponsored research funding derived from Federal (NIH, DoD, NSF), State (CPRIT), Foundation/Philanthropic, and Biopharma/Pharmaceutical research funding proposals (RFPs)

Therapeutic Areas: Oncology (Hematology and Solid Tumor), Immunology, Neurology/CNS, Clinical Pharmacology, Digital Health (AI), Medical Device, Therapeutic Diagnostics, Healthcare Prevention, Educational Services and Other Indications

Specialties: Clinical Operations, Business Development, Research Proposal Management, Clinical Trial Management, Business Entrepreneurship, ICH/GCP guidelines, GLP/GMP regulations, Research Analytics, People Leadership and Human Resource Management.

With less than 10% of investigational products making it to post-marketing surveillance during clinical trials, it is imperative to build a statistical analysis plan for any clinical study, Dr. Cheng brought to HMC of extensive and flexible biostatistical capabilities for different phases of clinical trials. Under his guidance, each analysis is custom built based on our client’s clinical research goals, and performed to ICH-GCP standards, and uses the latest, best-in-class statistical software.

Dr. Cheng’s extensive experience in clinical data analysis allows HMC to provide an individualized service offering for our clients in each clinical trial, regardless of the complexity of the biostatistical needs, from study design, to sample size calculation, to protocol development & review, to randomization, and statistical analysis plans, analysis and Interpretation, data presentation and reports. Biostatistician is the key driver behind trial design, it’s one of the key components of clinical trial design, for many studies, regulatory agencies review the statistical analysis plan (SAP) as part of the trial design review.

Dr. Cheng obtained his Ph.D. in Pharmaceutical Science from University of Arizona